Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 38
Filter
Add more filters










Publication year range
1.
Int J Surg ; 8(6): 489-93, 2010.
Article in English | MEDLINE | ID: mdl-20633707

ABSTRACT

INTRODUCTION: Patients presenting acutely with symptomatic gallstone-related disease have historically had their laparoscopic cholecystectomy (LC) deferred due to perceived increased operative risks in the acute setting, particularly conversion to open surgery. The aim of this study was to compare morbidity and mortality between unselected cohorts of patients undergoing elective and 'emergency' LC in a District General Hospital. METHODS: All gallstone-related elective and emergency admissions under the care of two specialist laparoscopic surgeons during a two-year period were included. Patients admitted acutely with a diagnosis of biliary colic, acute cholecystitis or gallstone pancreatitis underwent 'emergency' LC during the same admission. Data were collected prospectively on patient demographics, inpatient stay, post-operative course and POSSUM scores. RESULTS: 423 patients underwent LC, of which 301 (71.1%) were elective and 122 (28.9%) were 'emergency' procedures. ASA grades and POSSUM physiologic scores were similar between the two groups. The overall morbidity rates were similar in the emergency and elective groups (13.1% vs. 7.3%, p = 0.088), and there was no significant difference in the rates of major complications including conversion to open surgery (0% vs. 0.3%, NS), bile leak or re-operation between the two groups. 30-day mortality rates were similar in the two groups (0.8% vs. 0%, NS). CONCLUSION: When performed by specialist laparoscopic surgeons, LC in the acute setting is safe with mortality and morbidity rates, including conversion to open surgery, comparable to elective LC.


Subject(s)
Cholecystectomy, Laparoscopic/methods , Cholecystitis, Acute/surgery , Emergencies , Gallstones/complications , Hospitals, Special , Pancreatitis/surgery , Adolescent , Adult , Aged , Aged, 80 and over , Cholecystitis, Acute/epidemiology , Cholecystitis, Acute/etiology , Female , Follow-Up Studies , Gallstones/surgery , Humans , Incidence , Male , Middle Aged , Pancreatitis/epidemiology , Pancreatitis/etiology , Retrospective Studies , Survival Rate , Treatment Outcome , United Kingdom/epidemiology , Young Adult
2.
Hernia ; 14(4): 345-9, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20358239

ABSTRACT

BACKGROUND: Trans-abdominal laparoscopic inguinal hernia repair allows rapid assessment and exploration of the contralateral groin and repair of an occult hernia. Although previous studies have shown that the totally extra-peritoneal (TEP) hernia repair can be used to assess the contralateral groin, there is little data pertaining to the trans-abdominal pre-peritoneal (TAPP) approach. The aim of this study was to document the incidence of occult contralateral hernia at the time of TAPP hernia repair. METHODS: Data were collected prospectively from all patients undergoing laparoscopic TAPP hernia repair in a District General Hospital over a three-year period. Two specialist laparoscopic/upper gastrointestinal surgeons undertook all of the operations and telephone follow-up was carried out by a dedicated laparoscopic specialist nurse. RESULTS: A total of 310 patients underwent hernia surgery. Four cases were excluded, leaving 306 patients in the study. The male:female ratio was 10.5:1, with a median age of 59 years. Two hundred and six (67%) patients were booked for a unilateral hernia repair; of these, a contralateral hernia was found and repaired in 45 (22%). In 76 cases where a bilateral repair was planned, 61 (80%) went on to have both groin defects repaired. In the remaining 20%, the clinical suspicion of bilateral hernia was revised at the time of surgery to unilateral only. Twenty (7%) patients were booked to undergo a unilateral repair with the possibility of a contralateral hernia--in this group, the suspected contralateral defect was confirmed in 6 (30%) cases. Four (1%) cases were booked as femoral repairs, one of which was found to be an inguinal hernia. The clinical diagnostic accuracy was 78%. CONCLUSION: Accurate incidence figures of an occult contralateral inguinal hernia will enhance the pre-operative information given to patients and may impact on resource allocation and planning theatre logistics. Finding and repairing an occult contralateral hernia at the time of TAPP has the distinct advantage that it saves the patient from further symptoms and from another operation with its associated potential morbidity.


Subject(s)
Hernia, Femoral/epidemiology , Hernia, Femoral/surgery , Hernia, Inguinal/epidemiology , Hernia, Inguinal/surgery , Female , Hernia, Femoral/diagnosis , Hernia, Inguinal/diagnosis , Humans , Incidence , Laparoscopy , Male , Middle Aged , Prospective Studies
3.
Retina ; 21(4): 339-43, 2001.
Article in English | MEDLINE | ID: mdl-11508879

ABSTRACT

PURPOSE: To report the stability of acquired immunodeficiency syndrome (AIDS)-associated cytomegalovirus (CMV) retinitis lesions that have undergone regression in the absence of specific anti-CMV medications owing to highly active antiretroviral therapy (HAART)-generated immune recovery. METHODS: The initial examination revealed HAART-associated regression of CMV retinitis lesions in eight subjects at two institutions. Patients were monitored for recurrences of CMV activity. CD4+ T-lymphocyte counts and human immunodeficiency virus (HIV) loads were measured. RESULTS: All patients had positive initial responses to HAART with an average HIV load decrease of 2.26 log units (range 0.3-5.57). Mean CD4+ T-lymphocyte count at baseline was 45.6 (range 4-107) and increased by an average of 132.5 (range 7-266) within the first 2 to 4 months of HAART. Patients were observed for an average of 15.5 months (range 11-20 months). Six subjects had a vigorous and sustained response to therapy, achieving an average HIV load of 9,400 copies/mL (3.32 log10 decrease) and CD4+ T-lymphocyte count of 158.2 cells/microL. These patients had no CMV retinitis progression. By contrast, two others who attained an average log10 decrease of only 0.48 had modest and short-lived increases in the CD4+ T-lymphocyte count. These patients experienced reactivation of CMV retinitis after 5 and 7 months, respectively. CONCLUSIONS: Regressed CMV retinitis may remain healed for long periods. However, failure of HAART to induce substantial decreases in HIV load may predict poor or unsustainable rises in the CD4+ T-lymphocyte count and presage recurrence of CMV retinitis. Vigilance in ophthalmic examinations is especially mandatory in these subjects.


Subject(s)
AIDS-Related Opportunistic Infections/physiopathology , Antiretroviral Therapy, Highly Active , Cytomegalovirus Retinitis/physiopathology , AIDS-Related Opportunistic Infections/immunology , AIDS-Related Opportunistic Infections/virology , Anti-HIV Agents/therapeutic use , CD4 Lymphocyte Count , CD4-Positive T-Lymphocytes/immunology , Cytomegalovirus Retinitis/immunology , Cytomegalovirus Retinitis/virology , HIV-1/genetics , HIV-1/physiology , Humans , Prognosis , RNA, Viral/genetics , Recurrence , Viral Load , Virus Activation
4.
AIDS Patient Care STDS ; 14(7): 343-6, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10935050

ABSTRACT

Cytomegalovirus retinitis (CMVR) is the most common intraocular infection encountered in ophthalmic practices. To assess the impact of highly active antiretroviral therapy (HAART) on the incidence of CMVR and subsequent retinal detachments, a retrospective review of the HIV+ patients seen at a single university and community-based practice between 1992-1993 (group 1), before the advent of protease inhibitors, was compared with the data obtained from October 1996 to October 1997 (group 2) and October 1997-1998 (group 3), after the widespread use of HAART. The incidence of CMVR and retinal detachment rates for each group was calculated and compared. Twenty five (2.6%) of 974 HIV+ patients in group 1 developed CMVR. Of these, four patients developed retinal detachment (16%). Group 2 had a total of 1084 HIV+ patients, 18 (1.7%) of whom developed CMVR, which indicates a 35% decline of the incidence of CMV retinitis at our institution (p = 0.052, Odds ratio = 0.533, Confidence interval 0.28-1.01) and three patients (20%) developed retinal detachment. Only 1 patient (0.07%) of 1274 patients in group 3 developed CMVR, which represents a 99% reduction since 1993 (p = 0.0000000456). We conclude that the incidence of CMVR at this institution has decreased significantly with the recent use of HAART therapy. This effect may be related to the aggressive use of HAART and associated immune recovery in this population of AIDS patients. In this small series, however, the rate of retinal detachment appeared unchanged, but was only observed in those individuals who were not on HAART or who had just recently started.


Subject(s)
AIDS-Related Opportunistic Infections/epidemiology , Anti-HIV Agents/therapeutic use , Cytomegalovirus Retinitis/epidemiology , Retinal Detachment/epidemiology , AIDS-Related Opportunistic Infections/prevention & control , Adult , Antiretroviral Therapy, Highly Active , California/epidemiology , Cytomegalovirus Retinitis/prevention & control , Female , Humans , Incidence , Male , Retinal Detachment/prevention & control , Retrospective Studies
6.
Ophthalmology ; 107(5): 877-81; discussion 881-3, 2000 May.
Article in English | MEDLINE | ID: mdl-10811078

ABSTRACT

OBJECTIVE: To characterize cytomegalovirus (CMV) retinitis in human immunodeficiency virus (HIV)-infected patients who demonstrate immune recovery while receiving highly active antiretroviral therapy (HAART). DESIGN: Consecutive, noncomparative case series. PARTICIPANTS: Twenty-two HIV-positive patients, from two institutions, with a history of CMV retinitis, and with elevated CD4 cell counts after HAART. MAIN OUTCOME MEASURES: Duration of healed CMV retinitis without anti-CMV therapy, CD4 cell count, and HIV viral load. INTERVENTION: Discontinuation of anti-CMV therapy after persistent elevation of CD4 cell count over 50 cell/mm3 (median, 161/mm3; range, 85-408/mm3). RESULTS: The median period of healed CMV retinitis without anti-CMV therapy was 72 weeks (range, 33-116 weeks). Nineteen of 22 patients were still healed without anti-CMV therapy at study end. The three patients with CMV retinitis progression simultaneously had HAART, fail with CD4 cell counts of 37, 35, and 47/mm3. CONCLUSIONS: HIV-positive patients with CMV retinitis, who demonstrate a sustained HAART-induced elevation of CD4 cell count on two consecutive counts 3 months apart and whose retinitis remains healed on anti-CMV therapy for greater than 4 months, are likely to remain healed if the anti-CMV therapy is withdrawn. It is important to monitor these patients with indirect ophthalmoscopy because HAART failure may occur and allow CMV retinitis reactivation.


Subject(s)
AIDS-Related Opportunistic Infections/immunology , Antiviral Agents/therapeutic use , CD4-Positive T-Lymphocytes/physiology , Cytomegalovirus Retinitis/immunology , AIDS-Related Opportunistic Infections/diagnosis , AIDS-Related Opportunistic Infections/drug therapy , Adult , CD4 Lymphocyte Count , Cytomegalovirus/genetics , Cytomegalovirus/growth & development , Cytomegalovirus Retinitis/diagnosis , Cytomegalovirus Retinitis/drug therapy , Drug Therapy, Combination , Female , HIV-1/genetics , HIV-1/growth & development , Humans , Male , Middle Aged , RNA, Viral/analysis , Time Factors , Virus Activation/drug effects
7.
J Med Genet ; 37(12): 927-32, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11106356

ABSTRACT

INTRODUCTION: Papillon-Lefèvre syndrome (PLS) is an autosomal recessive disorder characterised by palmoplantar keratoderma and severe, early onset periodontitis, which results from deficiency of cathepsin C activity secondary to mutations in the cathepsin C gene. To date, 13 different cathepsin C mutations have been reported in PLS patients, all of which are homozygous for a given mutation, reflecting consanguinity. AIM: To evaluate the generality of cathepsin C mutations in PLS, we studied an ethnically diverse group of 20 unrelated families. METHODS: Mutations were identified by direct automated sequencing of genomic DNA amplified for exonic regions and associated splice site junctions of the cathepsin C gene. Long range PCR was performed to determine the genomic structure of the cathepsin C gene. RESULTS: The cathepsin C gene spans over 46 kb, with six introns ranging in size from 1.6 to 22.4 kb. Eleven novel mutations and four previously reported mutations were identified in affected subjects from 14 families. Missense mutations were most common (9/15), followed by nonsense mutations (3/15), insertions (2/15), and deletions (1/15). Among these 14 probands, two were compound heterozygotes. Affected subjects with transgressions of the dermal lesions onto the knees or elbows or both had mutations in both the pro- and mature regions of the enzyme, although most were in the mature region. CONCLUSION: Mutations in the mature region of cathepsin C were more likely to be associated with the transgressions of the dermatological lesions, although the results were not statistically significant. A comprehensive list of all cathepsin C mutations described to date, representing 25 mutations from 32 families with PLS and related conditions, is also presented.


Subject(s)
Cathepsin C/genetics , Mutation/genetics , Papillon-Lefevre Disease/ethnology , Papillon-Lefevre Disease/genetics , Periodontitis/ethnology , Periodontitis/genetics , Cathepsin C/blood , Cathepsin C/metabolism , Consanguinity , DNA Mutational Analysis , Female , Humans , Male , Papillon-Lefevre Disease/enzymology , Periodontitis/enzymology , Syndrome
8.
Am J Ophthalmol ; 127(2): 223-4, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10030575

ABSTRACT

PURPOSE: To report atypical clinical features of Bartonella henselae neuroretinitis treated with combination antibiotics. METHOD: Case report. RESULTS: A 20-year-old man with a positive B. henselae titer developed a unilateral neuroretinitis, a large peripapillary angiomatous lesion, branch artery occlusion with ischemic maculopathy, and vision loss that failed to improve with clindamycin. Treatment with doxycycline and rifampin led to rapid clinical improvement. The severe vision loss in this case is atypical. CONCLUSIONS: Ocular findings associated with B. henselae infection may include retinal angiomatous lesion and branch retinal artery occlusion. Doxycycline and rifampin were successful in treating the infection.


Subject(s)
Bartonella henselae , Blindness/microbiology , Cat-Scratch Disease/microbiology , Eye Infections, Bacterial/microbiology , Hemangioma, Capillary/microbiology , Retinal Artery Occlusion/microbiology , Retinal Neoplasms/microbiology , Adult , Antibodies, Bacterial/analysis , Bartonella henselae/immunology , Blindness/drug therapy , Blindness/pathology , Cat-Scratch Disease/drug therapy , Cat-Scratch Disease/pathology , Doxycycline/therapeutic use , Drug Therapy, Combination/therapeutic use , Enzyme-Linked Immunosorbent Assay , Eye Infections, Bacterial/drug therapy , Eye Infections, Bacterial/pathology , Fluorescein Angiography , Fundus Oculi , Hemangioma, Capillary/drug therapy , Hemangioma, Capillary/pathology , Humans , Male , Optic Neuritis/drug therapy , Optic Neuritis/microbiology , Optic Neuritis/pathology , Retinal Artery Occlusion/drug therapy , Retinal Artery Occlusion/pathology , Retinal Neoplasms/drug therapy , Retinal Neoplasms/pathology , Retinal Vessels/pathology , Retinitis/drug therapy , Retinitis/microbiology , Retinitis/pathology , Rifampin/therapeutic use , Visual Acuity
9.
Retina ; 18(5): 443-7, 1998.
Article in English | MEDLINE | ID: mdl-9801041

ABSTRACT

PURPOSE: To report the development of vitreomacular traction syndrome (VMT) following highly active antiretroviral therapy (HAART) in AIDS patients with cytomegalovirus retinitis (CMV-R). METHODS: We identified two AIDS patients with evidence of CMV-R who later developed VMT following HAART-associated immune recovery vitritis. RESULTS: The CD4+ T-lymphocyte count increased from 5 to 190 cells/microL in Patient 1 and from 26 to 713 cells/microL in Patient 2. HIV-RNA copies/mL decreased from 341,000 to less than 400 in Patient 1 and from 43,900 to less than 400 in Patient 2. Increased vitreous inflammation occurred during this period of immune recovery. After resolution of vitritis, VMT developed in both patients and was confirmed by B-scan ultrasound and fluorescein angiography. In both patients, CMV-R was clinically inactive at the time of VMT development. Both patients underwent pars plana vitrectomy with peeling of the posterior hyaloid, which confirmed VMT intraoperatively. CONCLUSIONS: VMT appears to be a sequelae of HAART-associated immune recovery vitritis in AIDS-related CMV-R. Changes in immune status may permit an inflammatory response that can lead to VMT. As advances in pharmacologic intervention continue, clinical manifestations and ocular sequelae in CMV-R will change, as will the approach and management of this disease.


Subject(s)
AIDS-Related Opportunistic Infections/drug therapy , Antiviral Agents/adverse effects , Cytomegalovirus Retinitis/drug therapy , Eye Diseases/chemically induced , Vitreous Body/drug effects , AIDS-Related Opportunistic Infections/immunology , AIDS-Related Opportunistic Infections/pathology , Adult , CD4 Lymphocyte Count , Cytomegalovirus Retinitis/immunology , Cytomegalovirus Retinitis/pathology , Eye Diseases/diagnostic imaging , Eye Diseases/surgery , Follow-Up Studies , HIV-1/genetics , Humans , Male , RNA, Viral/analysis , Retrospective Studies , Syndrome , Ultrasonography , Visual Acuity , Vitrectomy , Vitreous Body/diagnostic imaging , Vitreous Body/surgery
10.
J Infect Dis ; 177(5): 1182-7, 1998 May.
Article in English | MEDLINE | ID: mdl-9593001

ABSTRACT

The suppression of human immunodeficiency virus (HIV) replication and elevation in CD4 cells observed with protease inhibitor combination regimens known as HAART (highly active antiretroviral therapy) may allow AIDS patients to undergo an immune recovery that allows them to suppress the progression of cytomegalovirus (CMV) retinitis. Eleven AIDS patients receiving HAART with healed CMV retinitis in whom CMV-specific maintenance therapy was discontinued were studied. Median CD4 cell counts were 42 before the initiation of HAART and 183 at discontinuation of anti-CMV therapy. While a median 1.1 log10 drop in plasma HIV-1 RNA was obtained between starting HAART and withdrawal of maintenance therapy for CMV, only 3 of 11 patients maintained plasma HIV RNA below the limits of detection. Reactivation of CMV retinitis after withdrawal of anti-CMV therapy did not occur in any of the patients observed for a median of 156 days (range, 92-558).


Subject(s)
AIDS-Related Opportunistic Infections/immunology , Acquired Immunodeficiency Syndrome/drug therapy , Anti-HIV Agents/therapeutic use , Antiviral Agents/therapeutic use , CD4 Lymphocyte Count , Cytomegalovirus Retinitis/drug therapy , Cytomegalovirus Retinitis/immunology , Cytomegalovirus/growth & development , HIV Protease Inhibitors/therapeutic use , Organophosphonates , Virus Activation , AIDS-Related Opportunistic Infections/virology , Acquired Immunodeficiency Syndrome/immunology , Adult , Cidofovir , Cytomegalovirus/drug effects , Cytomegalovirus/isolation & purification , Cytomegalovirus Retinitis/virology , Cytosine/analogs & derivatives , Cytosine/therapeutic use , Drug Therapy, Combination , Female , HIV-1/physiology , Humans , Male , Organophosphorus Compounds/therapeutic use , Recurrence , Virus Activation/drug effects , Virus Replication
11.
Ophthalmology ; 105(3): 459-66, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9499776

ABSTRACT

OBJECTIVE: This study aimed to report the long-term outcomes of patients treated with an antibiotic drug combination for Bartonella henselae neuroretinitis. DESIGN: The study design was a retrospective case series. PARTICIPANTS: Seven consecutive patients with neuroretinitis and cat scratch disease participated. INTERVENTIONS: Patients underwent medical and ophthalmic evaluations. Blood cultures were obtained, and B. henselae antibody titers were measured. Tuberculosis, Lyme, toxoplasmosis, syphilis, and sarcoidosis were excluded. Patients received oral doxycycline 100 mg and rifampin 300 mg twice daily for 4 to 6 weeks and were observed for an average of 16 months (range, 10-24 months). Formal electrophysiologic testing was performed in three patients after resolution of neuroretinitis. MAIN OUTCOME MEASURES: The changes in ocular inflammation and visual function associated with treatment were recorded. Follow-up examinations and electrophysiologic testing documented sequelae. RESULTS: Patients presented following cat exposure with fever, malaise, and blurred vision. Decreased visual acuity (ranging from 20/40 to counting fingers) frequently was associated with dyschromatopsia and afferent pupillary defects. Ophthalmoscopic analysis showed signs of neuroretinitis, including nerve fiber layer hemorrhages, cotton-wool spots, multiple discrete lesions in the deep retina, and stellate macular exudates. B. henselae infection was confirmed with positive blood cultures or elevated immunofluorescent antibody titers or both. Therapy appeared to promote resolution of neuroretinitis, restoration of visual acuity, and clearance of bacteremia. After 1 to 2 years, two eyes had residual disc pallor, afferent pupillary defects, retinal pigmentary changes, and mildly decreased visual acuity. Electrophysiologic studies showed that when compared to the fellow eye, affected eyes had subnormal contrast sensitivity, abnormal color vision, and abnormal visually evoked potentials. Conversely, electroretinograms were normal in all subjects. CONCLUSIONS: B. henselae is a cause of neuroretinitis in cat scratch disease. Compared to historic cases, doxycycline and rifampin appeared to shorten the course of disease and hasten visual recovery. Long-term prognosis is good, but some individuals may acquire a mild postinfectious optic neuropathy.


Subject(s)
Bartonella henselae/isolation & purification , Cat-Scratch Disease/diagnosis , Drug Therapy, Combination/therapeutic use , Eye Infections, Bacterial/diagnosis , Optic Neuritis/diagnosis , Retinitis/diagnosis , Adult , Antibodies, Bacterial/analysis , Bartonella henselae/immunology , Cat-Scratch Disease/complications , Cat-Scratch Disease/drug therapy , Color Perception , Contrast Sensitivity , Doxycycline/therapeutic use , Electroretinography , Evoked Potentials, Visual , Eye Infections, Bacterial/drug therapy , Eye Infections, Bacterial/microbiology , Female , Fluorescein Angiography , Fundus Oculi , Humans , Male , Optic Neuritis/drug therapy , Optic Neuritis/microbiology , Retinitis/drug therapy , Retinitis/microbiology , Retrospective Studies , Rifampin/therapeutic use , Visual Acuity
12.
Am J Ophthalmol ; 125(3): 409-11, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9512170

ABSTRACT

PURPOSE: To report the response of acute Behçet retinitis to high-dose corticosteroids. METHOD: Case report. A 58-year-old man with Behçet disease and severe bilateral glaucoma experienced a sudden decrease of visual acuity to counting fingers in his (better-seeing) left eye. Examination disclosed hypopyon uveitis and an infiltrative retinitis threatening the fovea. He received intravenous methylprednisolone hemisuccinate, 1 gram per hour on each of 3 successive days, followed by oral prednisone and cyclosporine. RESULTS: The retinal infiltrate disappeared within 24 hours. Visual acuity improved to LE, 20/400 by day 5 and returned to LE, 20/30 after 3 months. A visual field demonstrated a scotoma corresponding to the location of the previous retinitis. CONCLUSION: High-dose intravenous methylprednisolone can reverse severe vision loss in acute Behçet retinitis.


Subject(s)
Behcet Syndrome/drug therapy , Glucocorticoids/administration & dosage , Methylprednisolone Hemisuccinate/administration & dosage , Retinitis/drug therapy , Acute Disease , Behcet Syndrome/pathology , Behcet Syndrome/physiopathology , Cyclosporine/administration & dosage , Humans , Immunosuppressive Agents/administration & dosage , Infusions, Intravenous , Male , Middle Aged , Prednisone/administration & dosage , Retinitis/pathology , Retinitis/physiopathology , Visual Acuity , Visual Fields
13.
AIDS Patient Care STDS ; 12(3): 181-5, 1998 Mar.
Article in English | MEDLINE | ID: mdl-11361932

ABSTRACT

The aggressive multidrug regimen of highly active antiretroviral therapy (HAART) has offered some degree of promise of immune reconstitution in AIDS patients, a phenomenon that theoretically would impact positively on the incidence and severity of opportunistic infections. Some studies already have noted complete regression of cytomegalovirus (CMV) retinitis without specific use of anti-CMV agents in patients undergoing HAART. However, the role of HAART in CMV retinitis remains controversial among investigators. This review of the salient details regarding the controversies associated with CMV retinitis and the immune recovery hypothesis is meant to shed light on current and future therapeutic issues concerns. Early data seem to predict a decline in CMV retinitis. However, some investigators have noted that increased CD4 T-lymphocyte counts may not protect against CMV retinitis; therefore, the diagnosis cannot be excluded based on count alone. There is also the question of whether CMV retinitis progression in any way represents failure of HAART in those patients receiving this type of combination therapy. HAART is seen as an encouraging development in the treatment of AIDS and opportunistic infection, but its more specific therapeutic effect on CMV retinitis requires further research with controlled prospective clinical trials.


Subject(s)
AIDS-Related Opportunistic Infections/drug therapy , Anti-HIV Agents/therapeutic use , Cytomegalovirus Retinitis/drug therapy , AIDS-Related Opportunistic Infections/diagnosis , AIDS-Related Opportunistic Infections/immunology , Clinical Trials as Topic , Cytomegalovirus Retinitis/diagnosis , Cytomegalovirus Retinitis/immunology , Dose-Response Relationship, Drug , Drug Therapy, Combination , Female , Humans , Male , Prognosis , Treatment Outcome
14.
Am J Ophthalmol ; 124(2): 199-205, 1997 Aug.
Article in English | MEDLINE | ID: mdl-9262543

ABSTRACT

PURPOSE: To report the observation that anti-retroviral therapy that includes a protease inhibitor can induce the regression of cytomegalovirus retinitis without requiring specific anticytomegalovirus drug therapy. METHODS: We examined the fundi of four patients with advanced acquired immunodeficiency syndrome (AIDS) who were placed on highly active antiretroviral therapy consisting of two nucleoside analogs and a protease inhibitor. The combined medications resulted in increased CD4+ T-lymphocyte counts and decreased load of human immunodeficiency virus (HIV-1). A prospective evaluation of the effect of these medications on an active cytomegalovirus retinitis lesion was conducted in one patient. Retinal lesions were documented with fundus photography. RESULTS: None of these patients received specific anticytomegalovirus medications. The average baseline CD4+ T-lymphocyte count was 33 cells per microliter (range, 4 to 88 cells per microliter) and increased an average of 118.5 cells per microliter (range, 66 to 185 cells per microliter). Average baseline plasma HIV-1 viral loads (HIV-1-RNA copies per ml) decreased 1.46 log units (range, 0.65 to 2.93 log units). In one patient, posterior progression (border advancement toward the posterior pole) of a cytomegalovirus retinitis lesion decelerated over time and stopped. Three other patients on initial examination had areas of retinal scarring consistent with healed cytomegalovirus retinitis. CONCLUSIONS: The addition of an HIV-1 protease inhibitor in the treatment of AIDS may lead to complete regression of cytomegalovirus retinitis without specific anticytomegalovirus medications. This effect may be related to reduced HIV-1 loads, a possible direct drug effect, an increase in CD4+ T-lymphocyte counts, or other associated changes in immune status.


Subject(s)
Acquired Immunodeficiency Syndrome/complications , Cytomegalovirus Infections/complications , Cytomegalovirus Infections/drug therapy , Protease Inhibitors/therapeutic use , Retinitis/virology , Acquired Immunodeficiency Syndrome/virology , Adult , Antiviral Agents/therapeutic use , CD4 Lymphocyte Count/drug effects , Cicatrix/etiology , Fundus Oculi , HIV-1/isolation & purification , Humans , Male , Middle Aged , Ophthalmoscopy , Prospective Studies , Retinitis/pathology
17.
J Epidemiol Community Health ; 44(1): 20-3, 1990 Mar.
Article in English | MEDLINE | ID: mdl-2348143

ABSTRACT

STUDY OBJECTIVE: The purpose of the study was to examine default rates in tuberculosis treatment in two hospitals in north India with different follow up arrangements. DESIGN: The study was a retrospective cohort study. SETTING: Two hospitals were involved. One was the District Tuberculosis Centre for the Kulu Valley area of Himachal Pradesh. The other was a private mission hospital serving the same area. PATIENTS: The study involved 321 patients at the tuberculosis centre and 381 at the mission hospital, being all those newly diagnosed with tuberculosis from October 1982 to September 1983; follow-up to October 1984. Patients at the mission hospital were more affluent and had travelled much further to seek treatment; only one reminder was sent to defaulters from treatment. The government hospital had a more active response if the patients missed an appointment, with a home visit by a health worker. RESULTS: Rates of permanent default were similar in each hospital and were very high: approximately 40% at 6 months, 60% at 12 months, and 65% at 18 months of treatment. CONCLUSIONS: Default was a major problem irrespective of the follow up procedures employed. Recommendations are made concerning treatment and follow up, including better communication about the disease and its treatment, active follow up of defaulters, and review of treatment policies.


Subject(s)
Outpatient Clinics, Hospital , Patient Dropouts , Tuberculosis/drug therapy , Adolescent , Adult , Aged , Female , Hospitals, District , Hospitals, Voluntary , Humans , India , Male , Middle Aged , Retrospective Studies
18.
Am J Physiol ; 256(3 Pt 1): C466-77, 1989 Mar.
Article in English | MEDLINE | ID: mdl-2564251

ABSTRACT

Pacemaker activity in the canine proximal colon occurs at the submucosal and myenteric borders of the circular layer [Am. J. Physiol. 252 (Cell Physiol. 21): C215-C224 and C290-C299, 1987]. The present study investigated the neural regulation of rhythmic electrical activity. Spontaneous inhibitory junction potentials (IJPs) were observed in intracellular recordings from circular muscle cells near the myenteric border. The amplitudes of these events decayed with distance through the circular layer. Stimulation at the myenteric plexus surface evoked IJPs that mimicked the spontaneous events. Stimulation at the submucosal surface evoked IJPs in adjacent cells that were of shorter duration and of different waveform than myenteric IJPs. Amplitudes of IJPs evoked by stimulation near either surface decayed with distance from the site of stimulation. The decay functions for IJPs were essentially identical to the decay of spontaneous slow waves or myenteric potential oscillations. Spontaneous and evoked IJPs affected the amplitudes, durations, and patterns of ongoing rhythmic electrical activity. The data suggest that myenteric and submucosal pacemaker populations may be innervated by different populations of inhibitory nerve fibers. Innervation appears to be heterogeneous with dense populations of inhibitory nerve fibers predominantly located in the pacemaker regions. Neural regulations of pacemaker activity influences rhythmic electrical activity throughout the muscularis.


Subject(s)
Colon/physiology , Motor Neurons/physiology , Muscle, Smooth/physiology , Animals , Atropine/pharmacology , Colon/drug effects , Colon/innervation , Dogs , Electric Conductivity , Female , Hexamethonium , Hexamethonium Compounds/pharmacology , In Vitro Techniques , Intestinal Mucosa/drug effects , Intestinal Mucosa/physiology , Male , Membrane Potentials/drug effects , Microelectrodes , Muscle, Smooth/drug effects , Muscle, Smooth/innervation , Phentolamine/pharmacology , Propranolol/pharmacology , Tetrodotoxin/pharmacology
19.
J Pharmacol Exp Ther ; 248(1): 202-7, 1989 Jan.
Article in English | MEDLINE | ID: mdl-2913272

ABSTRACT

The effects of ethyl alcohol on the electrical and mechanical activities of canine gastric antral circular muscle were studied. Recently it has been reported that the circular layer of the antrum is not homogenous in its electrical activity. Therefore, circular muscles from the regions adjacent to the myenteric and submucosal borders of the circular layer were studied separately to compare the actions of ethyl alcohol through the thickness of the circular layer. In the first series of experiments concentration-response data were collected to describe the effects of ethyl alcohol on the contractile activities of myenteric and submucosal muscles. The data show that ethyl alcohol is more effective as an inhibitor of myenteric contractions than submucosal contractions. Next, experiments were performed to determine the electrical mechanism responsible for the contractile effects. Circular cells of submucosal and myenteric regions were impaled, and the muscles were exposed to several concentrations of ethyl alcohol ranging from 0.1 to 1.5%. Slow wave activity was reduced in frequency and amplitude in both regions. The inhibitory effect of ethyl alcohol on electrical activity was greater in submucosal muscles, but mechanical activity was less affected in these muscles because excitation-contraction coupling occurs at more polarized levels in the submucosal portion of the circular layer.


Subject(s)
Ethanol/pharmacology , Muscle Contraction/drug effects , Stomach/drug effects , Acetylcholine/pharmacology , Animals , Dogs , Dose-Response Relationship, Drug , Female , In Vitro Techniques , Male , Membrane Potentials/drug effects , Stomach/physiology
20.
Am J Physiol ; 255(6 Pt 1): C828-34, 1988 Dec.
Article in English | MEDLINE | ID: mdl-3202152

ABSTRACT

The effects of membrane potential on the waveforms and propagation of slow waves were tested using circular muscles of the canine colon. Studies were conducted with intracellular recording techniques on cross-sectional strips of canine proximal colon. Circular muscle cells near the submucosa generated slow waves that decayed in amplitude as they spread through the circular layer. The membrane potentials of cells were less negative as a function of distance from the submucosal border. Cells near the submucosa were depolarized with elevated external K+ and electrical pulses using the partitioned chamber technique. The waveforms of depolarized submucosal cells were compared with events recorded from cells in the bulk of the circular layer. The waveform changes caused by experimental depolarization were different from the changes in waveform that occur during propagation, suggesting the latter are due to a different mechanism than depolarization. The effects of the membrane potential on syncytial input resistance and length constant were also evaluated. The results of these studies are consistent with the hypothesis that slow-wave propagation across the circular layer in canine proximal colon occurs passively.


Subject(s)
Colon/physiology , Muscle, Smooth/physiology , Animals , Dogs , Electric Conductivity , In Vitro Techniques , Intestinal Mucosa/physiology , Membrane Potentials
SELECTION OF CITATIONS
SEARCH DETAIL
...